Evaluating the Chair Lift Test to Predict Outcomes in Adults with Non-Severe Pulmonary Embolism

What this Trial Is About

Researchers are evaluating the prognostic value of the chair lift test for assessing the severity of non-severe pulmonary embolism in hospitalized patients. This study compares the chair lift test results with the current pulmonary embolism risk score called sPESI, which is enhanced by cardiac biomarkers and measures of right ventricular dysfunction. The goal is to see how well the chair lift test predicts patient outcomes compared to established methods. Participants will perform the chair lift test, which involves repeated sit-to-stand movements at a comfortable pace for one minute. This test is being studied as an experimental method to evaluate pulmonary embolism severity. The primary measure is how sensitive and specific the chair lift test is, compared to the gold standard that includes biomarkers and heart function assessments. Secondary measures include troponin levels, presence of breathing difficulties six months later, and overall survival at six months. During the study, participants will undergo the chair lift test and have troponin measured within one day. They will be followed for six months to monitor symptoms and survival. Researchers will collect data on breathing problems after pulmonary embolism and overall health outcomes. The total study period extends through these assessments to understand the tests prognostic performance and its potential clinical use.

Interest of the Chair Lift Test in the Prognostic Evaluation of Pulmonary Embolism: a Single-center Open Prospective Study